Picking out Uncomplicated Products Of New Therapy for Gynecologic Cancer
Patients with gynecologic cancer have new expectation with a innovative technology currently made available at the Seidman Cancer Center at University Hospitals Case Medical Center. A team of cancer specialists, led by Robert DeBernardo, MD, is among the first in the nation to launch a dedicated program using Hyperthermic Intraperitoneal Chemotherapy (HIPEC) to treat ovarian, endometrial and select other cancers.
Completed as soon as possible following surgery, HIPEC supplies heated chemotherapy through a ‘hot bath’ into the abdominal cavity, where it can penetrate diseased tissue directly. Right after the physician removes all of the visible cancer as feasible, a heated, a sterilized chemotherapy solution is circulated all through the abdomen by way of a technically sophisticated perfusion system to destroy the surviving cancer cells.
“This is a new and potentially revolutionary way of treating women with gynecologic cancers, which tend to be quite responsive to chemotherapy,” says Dr. DeBernardo, gynecologic oncologist at UH Case Medical Center and Assistant Professor at Case Western Reserve University School of Medicine. “Our preliminary data and experience has been overwhelmingly positive and the therapy has been well-tolerated and effective. HIPEC promises to extend lives in a meaningful way.”
HIPEC has been used for years for public health care in patients with colon, pseudomyxomas, malignant mesothelioma and appendiceal cancer, varieties of cancer that usually ordinarily are not responsive to chemotherapy, however it’s currently viewed as an encouraging fresh treatment for gynecologic malignancy.